ClinicalTrials.gg
Sign In

Pulmonary Embolism clinical trials

The registry lists 832 studies for Pulmonary Embolism across more than 10 countries. 171 are recruiting or about to start. 455 of them are mainly about Pulmonary Embolism (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10.

ClinicalTrials.gov finds 1,007 studies for Pulmonary Embolism. How that becomes 832 here

This page counts the studies the registry files under Pulmonary Embolism, and those it files under no condition that list Pulmonary Embolismthemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 8, 2026. How condition pages count

  1. 1,007Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
  2. −9List Pulmonary Embolism as a condition, but the registry did not file them under itMost often written as “Pulmonary Embolism Acute” (5), “Acute Pulmonary Embolism” (2), and “Pulmonary Embolism Subacute Massive” (2). The registry filed them under other conditions only, most often Embolism (2) and Myocardial Infarction (2).
  3. −167Match it another way29 name it in the title, 4 in a keyword, and 134 by a synonym or other text the search reads.
  4. 831Counted here and found by its search48 of them list Pulmonary Embolism in their own words; the registry filed them under no condition.
  5. +1
    Counted here, but its search does not find them
  6. 832The count on this page

Get an email when these change. Save the Pulmonary Embolism studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
444
Recruiting
129
Status unknown
107
Terminated
48
Not yet recruiting
39
Withdrawn
30

Phase

Phase 3
84
Phase 4
70
Phase 2
39
Phase 1
15
Early Phase 1
12

Where

United States
236
France
138
Canada
74
China
72
Spain
60
Italy
57

Who runs them

Brigham and Women's Hospital (26) · University Hospital, Brest (20) · Assiut University (18) · Assistance Publique - Hôpitaux de Paris (17) · Bayer (15) · McMaster University (10) · University Hospital, Angers (10) · Centre Hospitalier Universitaire de Saint Etienne (10)

What is being tested here

Drugs under test in Pulmonary Embolism studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Apixaban5717
Rivaroxaban4820
Cenvacibart444
Tissue Plasminogen Activator1614
Aspirin158
Edoxaban137
Heparin124
Rosuvastatin113
Amrecibart111
Isoquercitrin111

Drug classes tested here Factor Xa inhibitors 8 open · Thrombolytics 1 open · NSAIDs 1 open

Coming up

15phase 3 studies under way
61studies finish main data collection within a year4 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 129 Pulmonary Embolism studies recruiting now, 109 (84%) set no upper age limit and 5 (4%) stop at 75 or younger. 9 (7%) take children under 18. 1 (1%) are for women only and 0 (0%) for men only; 9 (7%) take healthy volunteers.

Recruiting studies that take each age, of 129
AgeWomenMen
105 (4%)5 (4%)
18127 (98%)126 (98%)
30129 (100%)128 (99%)
40129 (100%)128 (99%)
50129 (100%)128 (99%)
65128 (99%)127 (98%)
75126 (98%)125 (97%)
85121 (94%)120 (93%)

Across all 832 studies, recruiting or not: 8% stop at 75 or younger and 3% at 65; 10% take children; 3% are for women only and <1% for men only; 8% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Pulmonary Embolism studies take

Of 31 phase 3 interventional studies under Pulmonary Embolism, half reached primary completion within 36 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 336 mo28–57 · 31 studies——
Phase 447 mo32–82 · 24 studies——
Interventional, no phase25 mo15–51 · 150 studies—27 mo15–55 · 125 studies
Observational47 mo21–105 · 160 studies—49 mo21–119 · 135 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Newly registered3

Studies

Recruiting first, then most recently updated. Showing 50 of 832. Browse all 832 → or search them.